AstraZeneca and Amgen’s Tezspire succeeds in Phase III nasal polyps trial
AstraZeneca and Amgen have released topline data from a Phase III trial of its inflammatory therapy, Tezspire (tezepelumab) in patients…
AstraZeneca and Amgen have released topline data from a Phase III trial of its inflammatory therapy, Tezspire (tezepelumab) in patients…
Castle Biosciences has released data from a multi-centre DECIDE study showing the impact of integrating its DecisionDx-Melanoma test results into…
Having raised the full-year sales guidance for Caplyta (lumateperone) a week ago, Intra-Cellular Therapeutics has reported positive topline data from…
Allurion Technologies has presented data from two studies showing the efficacy of its swallowable gastric balloon in causing significant weight…
US-based company Biofrontera has announced topline results from a Phase III trial evaluating its drug-device therapy, Ameluz gel and photodynamic…
Roche has presented new late-breaking data from a prospective trial showing that its Elecsys amyloid plasma panel can rule out…
Spero Therapeutics has suspended the development of its antibiotic SPR720, after the therapy failed to meet the primary endpoint in a Phase…
Bavarian Nordic is looking to expand the approval label of its MVA-BN mpox/smallpox vaccine to include children between two and…
Abbott has launched a “first-of-its-kind” trial to identify advanced heart failure patients who could potentially benefit from early advanced therapy…
US-based device company Luna Diabetes has initiated a pivotal trial evaluating its automated closed-loop insulin technology, the Luna System, in…